Global Innovative Platforms Inc
ir.giplinc.comWhat Do They Do?
Develops breath-based tests and air-analysis tools for animal health, including a heartworm test for dogs, for veterinarians and other animal-health users.
10-K for FY2025, filed Jan 13, 2026Global Innovative Platforms is focused on advancing animal health through breath analysis and air quality technology. We develop…View ↗
Advancements in technology have opened up numerous opportunities in the area of detecting and analyzing gasses for health-related…View ↗
We believe that the Heartworm Breath Test will bring forth a novel and differentiated tool that will assist veterinarians in identifying…View ↗
We are developing the Breath Test focused on detecting heartworm in dogs with the added benefits of earlier detection, non-invasive…View ↗
Who Are Their Customers?
The planned breath test is aimed at veterinarians, with samples expected to be analyzed through commercial labs run by the company or with partners. An animal-health company also collaborates on testing and provides access to animals and data.
10-K for FY2025, filed Jan 13, 2026 8-K, filed Jun 15, 2026Our revenue-producing collaboration has been extended through the end of July. The Company receives approximately $15,000 - $18,000 per…View ↗
How Are They Changing?
From merger search to animal testing
The older report described a shell company seeking a merger with an unidentified business; the latest describes a developer of breath-based animal disease tests and air-analysis tools.
10-K for FY2022, filed Mar 10, 2023 10-K for FY2025, filed Jan 13, 2026Global Innovative Platforms Inc. f/k/a Canning Street Corporation, a Delaware corporation, (“Global Innovative Platforms”, ”Canning…View ↗
Who Do They Compete With?
Competes with Idexx, Antech, and Zoetis
10-K for FY2025, filed Jan 13, 2026Currently, the three most popular Heartworm tests on the market are available through Idexx, Antech, and Zoetis. These animal health…View ↗
Loading...
